BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function

by Xuetian Yue, Yuhan Zhao, Juan Liu, Cen Zhang, Haiyang Yu, Jiabei Wang, Tongsen Zheng, Lianxin Liu, Jun Li, Zhaohui Feng, Wenwei Hu
Published 2015-08-01

P53 mediated cell motility in H1299 lung cancer cells

by Choi, Mi-Yon
Published 2010

A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer

by Maria Grzes, Magdalena Oron, Zuzanna Staszczak, Akanksha Jaiswar, Magdalena Nowak-Niezgoda, Dawid Walerych
Published 2020-06-01

Mutant p53 gain of function induces HER2 over-expression in cancer cells

by A. A. Román-Rosales, E. García-Villa, L. A. Herrera, P. Gariglio, J. Díaz-Chávez
Published 2018-07-01

Determining the Role of p53 Mutation in Human Breast Cancer Progression Using Recombinant Mutant/Wild-Type p53 Heterozygous Human Mammary Epithelial Cell Culture Models

by Junk, Damian Jerome
Published 2008

Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy

by Despina Siolas, Emily Vucic, Emma Kurz, Cristina Hajdu, Dafna Bar-Sagi
Published 2021-08-01

Cancer Cells Shuttle Extracellular Vesicles Containing Oncogenic Mutant p53 Proteins to the Tumor Microenvironment

by Bibek Bhatta, Ishai Luz, Christian Krueger, Fanny Xueting Teo, David P. Lane, Kanaga Sabapathy, Tomer Cooks
Published 2021-06-01

Structural and Drug Targeting Insights on Mutant p53

by Ana Sara Gomes, Helena Ramos, Alberto Inga, Emília Sousa, Lucília Saraiva
Published 2021-07-01

COMPARISON OF MUTANTP53 PROTEIN EXPRESSION IN PTERYGIUM GROUP WITH AND WITHOUT TRIAMCINOLONE ACETONITED INJECTION

by Riani Erna, Eva Kumalasari, Ika Kartika Edi
Published 2018-12-01

Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma

by Hai-long Ma, Shu-fang Jin, Wu-tong Ju, Yong Fu, Yao-yao Tu, Li-zhen Wang, Jiang-Li, Zhi-yuan Zhang, Lai-ping Zhong
Published 2017-08-01

Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations

by Toshinori Ozaki, Meng Yu, Danjing Yin, Dan Sun, Yuyan Zhu, Youquan Bu, Meixiang Sang
Published 2018-03-01

Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells

by Marco Cordani, Giovanna Butera, Raffaella Pacchiana, Francesca Masetto, Nidula Mullappilly, Chiara Riganti, Massimo Donadelli
Published 2020-02-01

Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells

by Zhu Hai-Bin, Yang Kai, Xie Yan-Qi, Lin Yi-Wei, Mao Qi-Qi, Xie Li-Ping
Published 2013-01-01

NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity

by Qijiong Li, Xiaofeng Liu, Kemin Jin, Min Lu, Chunfeng Zhang, Xiaojuan Du, Baocai Xing
Published 2017-08-01

Mutant P53 in pre-leukemic hematopoietic stem cells and the pathogenesis of Myelodysplastic Syndrome

by Chen, Sisi
Published 2018

Distinct Classes of Flavonoids and Epigallocatechin Gallate, Polyphenol Affects an Oncogenic Mutant p53 Protein, Cell Growth and Invasion in a TNBC Breast Cancer Cell Line

by Madhu Kollareddy, Luis A. Martinez
Published 2021-04-01

Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models

by Jin Wang, Yuan Hu, Vicente Escamilla-Rivera, Cassandra L. Gonzalez, Lin Tang, Bingbing Wang, Adel K. El-Naggar, Jeffrey N. Myers, Carlos Caulin
Published 2021-03-01

The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer

by Cen Zhang, Juan Liu, Jianming Wang, Tianliang Zhang, Dandan Xu, Wenwei Hu, Zhaohui Feng
Published 2021-02-01

Mutant p53 as a Regulator and Target of Autophagy

by Yong Shi, Erik Norberg, Helin Vakifahmetoglu-Norberg
Published 2021-02-01

The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas

by Fabio Valenti, Andrea Sacconi, Federica Ganci, Giuseppe Grasso, Sabrina Strano, Giovanni Blandino, Silvia Di Agostino
Published 2019-09-01